Passer au contenu principal
Dr Mohamad Abdel-Hadi
Score de confiance 8/100

Dr Mohamad Abdel-Hadi

Oncologie · Dammam

👤 5 ans d'expérience

10,610+ Patients seen
5 Years in practice
14 Publications
2 Languages spoken

À propos

Dr Mohamad Abdel-Hadi is a distinguished Consultant in Gynecologic Oncology with extensive experience in the field of women's health and cancer care. He is recognised for his leadership in establishing specialised oncology services within tertiary care settings in the region. His professional focus lies in the comprehensive management of gynaecological malignancies, where he combines clinical expertise with a dedication to patient-centred care. Dr Abdel-Hadi is also deeply involved in medical education, having served as a programme director for fellowship training, ensuring the next generation of specialists adheres to high standards of practice.
In his clinical practice, Dr Abdel-Hadi specialises in the diagnosis, surgical treatment, and long-term management of cancers affecting the female reproductive system, including ovarian, uterine, and cervical malignancies. He employs a multidisciplinary approach to complex cases, working closely to tailor treatment plans that address both the medical and emotional needs of his patients. His expertise extends to advanced surgical techniques required for intricate pelvic procedures, aiming to achieve the best possible oncological outcomes while preserving quality of life.
Dr Abdel-Hadi completed his medical training with an MBBS from the University of Jordan, followed by a residency in Obstetrics and Gynaecology at Jordan University Hospital. He further advanced his sub-specialisation by completing a Fellowship in Gynecologic Oncology at the Sydney Cancer Center and Royal Prince Alfred Hospital in Australia. He holds board certification in Obstetrics and Gynaecology and maintains an active interest in clinical research, particularly regarding risk factors for ovarian cancer in the region.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Mohamad Abdel-Hadi

Formation et études

  1. 2011–2017 MD · Medicine and Surgery
    Universitat de València, Dammam (SA)
  2. 2017–2021 Residency · Oncologie
    Universitat de Barcelona, Dammam (SA)

Carrière et postes

  1. 2021-09–2022-08 Junior consultant
    Universitat de València Teaching Hospital — Oncologie

Licences et assurance

Licences médicales

SA — Organización Médica Colegial de España (OMC)
#SA-766243 active · expires 2028-12-31

Certifications du conseil

European Board of Oncologie
#EB-9B1A9AB8 · issued 2022 · renewal 2032
Assurance responsabilité professionnelle : AmTrust Europe · 3,000,000 EUR couverture · No claims on file

Procédures réalisées

ProcédureCodeTotal à vie
GP consultation 99213 573
Annual physical exam 99395 723
Vaccination administration 90471 2,867
Minor procedure (skin) 17110 1,668

Services et tarifs

ServiceDuréeModalitéPrix
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 60 min in_clinic 270.00 EUR
Minor procedure (skin) 90 min in_clinic 360.00 EUR

Cabinet, équipe & en pratique

Mohamad Abdel-Hadi in consultation
IN OFFICE
Mohamad Abdel-Hadi with the team
WITH TEAM
Mohamad Abdel-Hadi at a conference
CONFERENCE

Vidéos

introduction · 145s
Meet Mohamad Abdel-Hadi

Recherche et publications

indice h : 21 · i10 : 11

  1. Long-term follow-up of Oncologie across SA
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2026
    DOI: 10.6175/euroclin.2026.0 · PMID: 33600566 · cité par 141
  2. Validation of clinical scoring in Oncologie
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2025
    DOI: 10.5933/euroclin.2025.1 · PMID: 33929234 · cité par 39
  3. Long-term follow-up of Oncologie across SA
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2024
    DOI: 10.6962/euroclin.2024.2 · PMID: 35975720 · cité par 9
  4. Validation of clinical scoring in Oncologie
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2023
    DOI: 10.5524/euroclin.2023.3 · PMID: 39102562 · cité par 99

Conférences invitées

  • Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
  • Single-centre experience in Oncologie National Society Meeting · Dammam · 2023 · oral abstract

Récompenses et adhésions

Récompenses

  • 🏆 Top-rated Oncologie — Dammam · EuroClinics Patient Choice · 2025 · regional

Adhésions à des sociétés

  • WONCA Europe — Family Doctors — Member · Depuis 2022
  • national college of family doctors — Member · Depuis 2022
  • European Union of Medical Specialists (UEMS) — Member · Depuis 2022

Articles de ce médecin

  • Patient education Patient guide to Oncologie
  • Awareness When should you see a oncologie?

Pour les patients internationaux

Coordinateur
Patient liaison · mohamad.abdel.hadi@euroclinics.example

Emplacement

1 balise

Avis des patients

Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
20 – 4 000 caractères

Les soumissions sont modérées et peuvent prendre 24-72 h pour apparaître publiquement. N'incluez pas d'informations identifiant le patient.

Avis récents

  • ★★★★★ ✓ Vérifié
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Vérifié
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Vérifié
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Spécialistes similaires

Tout parcourir →